Budesonide exerts a powerful topical anti-inflammatory effect on the respiratory and gastrointestinal systems. Budesonide administration can be via different routes such as oral, rectal, nasal, and inhalation. Each of these routes has gotten specific purposes, advantages, and disadvantages. The various budesonide formulations available in the market, depending on the indicated use, are administered as follows: the dosing of extended (delayed) release tablets and capsules is by mouth, suspension solution and powder are used for oral inhalation, over the counter spray for nasal application, and foam, enema, and suppositories for rectal administration. Patients should not chew, crush, or open the extended-release formulations. The inhaled formulation is available as a standalone inhaler or often combined with a long-acting beta-2 adrenergic agent.